Try our Advanced Search for more refined results
March 29, 2018
Forest Laboratories Holdings, Ltd. et al v. Mylan Pharmaceuticals Inc.
Case Number:
1:18-cv-00482
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 03, 2019
Mylan Gets 2030 Linzess Launch After Allergan Deal
Mylan Pharmaceuticals Inc. will hold off on its generic version of Allergan PLC and Ironwood Pharmaceuticals Inc.'s irritable bowel syndrome medication Linzess until February 2030 to end patent infringement litigation in West Virginia federal court.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login